查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2030 年亚太地区转染试剂和设备市场预测 - 区域分析 - 按产品、方法、应用和最终用户
市场调查报告书
商品编码
1562253

2030 年亚太地区转染试剂和设备市场预测 - 区域分析 - 按产品、方法、应用和最终用户

Asia Pacific Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product, Method, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 122 Pages | 订单完成后即时交付

价格

2022年亚太转染试剂和设备市场价值2.2223亿美元，预计2030年将达到4.1429亿美元；预计 2022 年至 2030 年复合年增长率为 8.1%。

日益增长的癌症经济负担推动亚太地区转染试剂和设备市场的发展

根据世界卫生组织 (WHO) 的数据，癌症是全球主要死亡原因之一，2020 年约有 1,000 万人死于癌症。将增加3020 万。根据2023年发表在《国际流行病学杂誌》上的文章《生活方式、遗传风险和癌症发病率》，近33%发生的癌症状况是遗传性的，该疾病发生基因突变的风险很高。因此，人们选择基因分析来早期检测和个人化治疗遗传性癌症病例。 BRCA1 和 BRCA2 有时被称为肿瘤抑制基因。继承这些基因之一的有害变异的人患多种癌症的风险更大，尤其是乳腺癌和卵巢癌等类型的癌症。与没有上述基因变异的人相比，这些人也往往在更年轻的时候罹患癌症。专注于癌细胞核酸加工的研究可能有助于了解癌症代谢。 DNA 通常被包装成病毒或非病毒颗粒，然后转移到待转染的细胞。基因转移已被提议作为增强抗肿瘤药物治疗难治性或转移性癌症有效性的新方法。据报导，基因疗法和药物（类似疗法）的结合可以增强经典疗法对肺癌、大肠癌、胰腺癌、膀胱癌和乳腺癌等的抗增殖作用。因此，癌症经济负担的加重支撑了亚太地区转染试剂和设备市场。

亚太地区转染试剂和设备市场概况

亚太地区分为中国、日本、印度、韩国、澳洲和亚太其他地区。到2022年，中国将占据最大的市场份额。这些国家有许多医疗机构为癌症患者提供治疗和护理服务。根据美国国立卫生研究院 (NIH) 的一项研究，2010 年至 2020 年间，中国癌症医院的年入院患者数量从 110 万人增加到 324 万人。根据《美国医学会杂誌》2023年发表的一项研究，中国大陆18岁及以上人群的慢性肾臟病（CKD）盛行率为8.2%。此外，国际癌症研究机构（IARC）的最新资料显示，中国胃癌的年龄标准化发生率（ASR）估计为每10万人中21例，粗率为33.06；对于胰臟癌，ASR 为每 10 万人 5 人，粗率为 8.6。根据同一来源，预计 2020 年 0-74 岁族群（男女）胃癌和胰臟癌新病例数分别为 478,508 例和 124,994 例。因此，慢性病的沉重负担推动了中国对CGT的需求，进而推动了转染试剂和设备市场的成长。

亚太地区转染试剂和设备市场收入及2030年预测（百万美元）

亚太地区转染试剂与设备市场区隔

亚太地区转染试剂和设备市场根据产品、方法、应用、最终用户和国家进行细分。

根据产品，亚太转染试剂和设备市场分为试剂和仪器。 2022 年，试剂细分市场将占更大份额。

从方法来看，亚太转染试剂和设备市场分为病毒方法、非病毒方法和混合方法。 2022 年，非病毒方法部分占最大份额。非病毒部分分为物理/机械方法和化学方法。此外，物理/机械方法细分为电穿孔、显微注射、生物弹体方法、雷射方法、磁转染和声穿孔。此外，化学方法细分为基于脂质体/高脂质和基于非脂质体/高脂质。

按应用划分，亚太地区转染试剂和设备市场分为生物医学研究、蛋白质生产和治疗递送。 2022 年，生物医学研究领域占最大份额。

根据最终用户，亚太地区转染试剂和设备市场分为学术和研究机构以及製药和生物技术公司。 2022 年，学术和研究机构领域占据了更大的份额。

依国家/地区划分，亚太地区转染试剂和设备市场分为澳洲、中国、印度、日本、韩国和亚太地区其他地区。 2022年，中国将主导亚太转染试剂和设备市场。

Fisher Scientific Inc、Promega Corp、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Mirus Bio LLC、QIAGEN NV、Merck KGaA、Lonza Group AG、MaxCyte Inc 和 Polyplus-Transfection SA 是营运中的一些领先公司亚太转染试剂和设备市场。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区转染试剂与设备市场 - 主要市场动态

  • 亚太地区转染试剂和设备市场 - 主要市场动态
  • 市场驱动因素
    • 细胞和基因疗法越来越受欢迎
    • 癌症带来的经济负担日益沉重
  • 市场限制
    • 仪器及耗材成本高
  • 市场机会
    • 将小规模流程升级为大规模流程
  • 未来趋势
    • 公司的策略倡议
  • 驱动因素和限制的影响：

第 5 章：转染试剂与设备市场 - 亚太市场分析

  • 2022-2030年亚太地区转染试剂与设备市场收入
  • 亚太地区转染试剂及设备市场预测分析

第 6 章：亚太地区转染试剂与设备市场分析 - 按产品

  • 试剂
  • 装置

第 7 章：亚太地区转染试剂与设备市场分析 - 依方式

  • 病毒性的
  • 非病毒性
  • 杂交种

第 8 章：亚太地区转染试剂与设备市场分析 - 按应用

  • 生物医学研究
  • 蛋白质生产
  • 治疗实施

第 9 章：亚太地区转染试剂和设备市场分析 - 依最终用户

  • 学术及研究机构
  • 製药和生物技术公司

第 10 章：亚太地区转染试剂与设备市场 - 国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 亚太地区其他地区

第 11 章：转染试剂与设备市场 - 产业格局

  • 概述
  • 2020-2023 年转染试剂和设备市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc

第 13 章：附录

Product Code: BMIRE00030389

The Asia Pacific transfection reagents and equipment market was valued at US$ 222.23 million in 2022 and is expected to reach US$ 414.29 million by 2030; it is estimated to register at a CAGR of 8.1% from 2022 to 2030.

Growing Economic Burden of Cancer Boosts Asia Pacific Transfection Reagents and Equipment Market

According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, and it accounted for ~10 million deaths in 2020. As per the International Agency for Research on Cancer, the global cancer burden is likely to increase with the addition of 30.2 million more cases by 2040. According to the Breast Cancer Organization, approximately 5-10% of breast cancer cases worldwide are hereditary and are caused by abnormal genes passed from generations. According to the article "Lifestyle, Genetic Risk and Incidence of Cancer," published in the International Journal of Epidemiology in 2023, nearly 33% of cancer conditions that occur are hereditary, and the risk of genetic mutations is high in the disease. Hence, people are opting for genetic profiling for the early detection and personalized treatment of hereditary cancer cases. BRCA1 and BRCA2 are sometimes referred to as tumor suppressor genes. People who inherit the harmful variants of one of these genes are at a greater risk of several cancers, most notably breast and ovarian cancer, among other types. These people also tend to develop cancer at younger ages compared to people who do not have variations in the said genes. Studies focused on nucleic acid processing by cancer cells are likely to help understand cancer metabolism. DNA is typically packaged into a viral or non-viral particle to be transferred into the cell that is to be transfected. Gene transfer has been proposed as a new approach to enhance the effectiveness of antitumor drugs in treating intractable or metastatic cancers. The association of gene therapy and drugs (similar therapy) has been reported to strengthen the antiproliferative effects of classical treatments in lung, colorectal, pancreatic, bladder, and breast cancers, among others. Thus, the elevating economic burden of cancer bolsters the Asia Pacific transfection reagents and equipment market.

Asia Pacific Transfection Reagents and Equipment Market Overview

The Asia Pacific region is classified into China, Japan, India, South Korea, Australia and rest of Asia Pacific. China holds the largest market share in the year 2022. Asia Pacific countries such as China, India, Singapore and more with a well-established healthcare system as well as fast-growing pharmaceutical and medical industries. These countries have many healthcare facilities providing treatment and care services to cancer patients. According to an NIH study, yearly patient admissions in cancer hospitals in China climbed from 1.10 million to 3.24 million during 2010-2020. According to a study published in 2023 in the Journal of the American Medical Association, chronic kidney disease (CKD) prevalence in people aged 18 years or older in Mainland China is recorded at 8.2%. Moreover, the latest data from the International Agency for Research on Cancer (IARC) indicates that the estimated age-standardized rate (ASR) for stomach cancer in China is 21 per 100,000, and the crude rate is 33.06; for pancreatic cancer, the ASR is 5 per 100,000 with the crude rate of 8.6. As per the same source, the estimated number of new cases of stomach cancer and pancreatic cancer in people aged 0-74 in 2020 (for both sexes) was 478,508 and 124,994, respectively. Thus, the high burden of chronic diseases propels the demand for CGTs in China, in turn, fueling the transfection reagents and equipment market growth.

Asia Pacific Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Transfection Reagents and Equipment Market Segmentation

The Asia Pacific transfection reagents and equipment market is segmented based on product, method, application, end user, and country.

Based on product, the Asia Pacific transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.

In terms of method, the Asia Pacific transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is subcategorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.

By application, the Asia Pacific transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.

Based on end user, the Asia Pacific transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.

Based on country, the Asia Pacific transfection reagents and equipment market is categorized into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific transfection reagents and equipment market in 2022.

Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc, and Polyplus-Transfection SA are some of the leading companies operating in the Asia Pacific transfection reagents and equipment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Transfection Reagents and Equipment Market - Key Market Dynamics

  • 4.1 Asia Pacific Transfection Reagents and Equipment Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Popularity of Cell and Gene Therapy
    • 4.2.2 Growing Economic Burden of Cancer
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments and Consumables
  • 4.4 Market Opportunities
    • 4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
  • 4.5 Future Trends
    • 4.5.1 Strategic Initiatives by Companies
  • 4.6 Impact of Drivers and Restraints:

5. Transfection Reagents and Equipment Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • 5.2 Asia Pacific Transfection Reagents and Equipment Market Forecast Analysis

6. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Product

  • 6.1 Reagents
    • 6.1.1 Overview
    • 6.1.2 Reagents: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Equipment
    • 6.2.1 Overview
    • 6.2.2 Equipment: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Modality

  • 7.1 Viral
    • 7.1.1 Overview
    • 7.1.2 Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.1 Retrovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.2 Adenovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.3 Adeno-Associated Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.4 Herpes Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Non-Viral
    • 7.2.1 Overview
    • 7.2.2 Non-Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.1 Physical/Mechanical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.1 Electroporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.2 Microinjection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.3 Biolistic Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.4 Laser Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.5 Magnetofection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.6 Sonoporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.2 Chemical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.1 Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.2 Non-Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Hybrid
    • 7.3.1 Overview
    • 7.3.2 Hybrid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Transfection Reagents and Equipment Market Analysis - by Application

  • 8.1 Biomedical Research
    • 8.1.1 Overview
    • 8.1.2 Biomedical Research: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Protein Production
    • 8.2.1 Overview
    • 8.2.2 Protein Production: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Therapeutic Delivery
    • 8.3.1 Overview
    • 8.3.2 Therapeutic Delivery: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Transfection Reagents and Equipment Market Analysis - by End Users

  • 9.1 Academic and Research Institutes
    • 9.1.1 Overview
    • 9.1.2 Academic and Research Institutes: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Pharmaceutical and Biotechnological Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical and Biotechnological Companies: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Transfection Reagents and Equipment Market -Country Analysis

  • 10.1 Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
    • 10.1.1 Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 China: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.1.2 China: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.1.2.1 China: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.1.2.2 China: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.1.2.2.1 China: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.1.2.2.2 China: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.1.3 China: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.1.4 China: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.1.2 Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.2.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.2.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.2.2.2.1 Japan: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.2.2.2.2 Japan: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.2.3 Japan: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.2.4 Japan: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.1.3 India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 India: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.3.2 India: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.3.2.1 India: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.3.2.2 India: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.3.2.2.1 India: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.3.2.2.2 India: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.3.3 India: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.3.4 India: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.1.4 South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.4.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.4.2.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.4.2.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.4.2.2.1 South Korea: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.4.2.2.2 South Korea: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.4.3 South Korea: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.4.4 South Korea: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.1.5 Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.5.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.5.2.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.5.2.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.5.2.2.1 Australia: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.5.2.2.2 Australia: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.5.3 Australia: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.5.4 Australia: Transfection Reagents and Equipment Market Breakdown, by End Users
      • 10.1.1.6 Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Product
        • 10.1.1.6.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.1.6.2.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.1.6.2.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.1.6.2.2.1 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.1.6.2.2.2 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
        • 10.1.1.6.3 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Application
        • 10.1.1.6.4 Rest of Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by End Users

11. Transfection Reagents and Equipment Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 F. Hoffmann-La Roche Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Bio-Rad Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Mirus Bio LLC
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 QIAGEN NV
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Merck KGaA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Lonza Group AG
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 MaxCyte Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us

List Of Tables

  • Table 1. Asia Pacific Transfection Reagents and Equipment Market Segmentation
  • Table 2. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 4. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
  • Table 5. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
  • Table 6. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
  • Table 7. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
  • Table 8. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
  • Table 9. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 10. Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
  • Table 11. Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 12. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 13. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 14. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 15. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 16. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 17. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 18. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 20. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 21. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 22. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 23. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 24. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 25. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 26. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 27. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 28. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 30. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 31. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 32. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 33. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 34. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 35. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 36. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 37. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 38. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 39. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 40. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 41. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 42. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 43. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 44. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 45. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 46. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 47. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 48. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 49. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 50. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 51. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 52. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 53. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 54. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 55. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 56. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 57. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 58. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 59. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
  • Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market

List Of Figures

  • Figure 1. Asia Pacific Transfection Reagents and Equipment Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Asia Pacific Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • Figure 4. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
  • Figure 5. Reagents: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 6. Equipment: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
  • Figure 8. Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Retrovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Adenovirus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Adeno-Associated Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Herpes Virus: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Non-Viral: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Physical/Mechanical: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Electroporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Microinjection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Biolistic Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Laser Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Magnetofection: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Sonoporation: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Chemical Method: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Non-Liposomal Based/High Lipid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Hybrid: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
  • Figure 26. Biomedical Research: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Protein Production: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Therapeutic Delivery: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Asia Pacific Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
  • Figure 30. Academic and Research Institutes: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pharmaceutical and Biotechnological Companies: Asia Pacific Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Asia Pacific: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
  • Figure 33. Asia Pacific: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 34. China: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Japan: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. India: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. South Korea: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 38. Australia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Rest of Asia Pacific: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023